Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis (Q34601335)

3 August 2017

title

Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis (English)

1 reference

3 August 2017

1 reference

Jun Lee

1

1 reference

3 August 2017

Yan Zhuang

2

1 reference

3 August 2017

Xin Wei

3

1 reference

3 August 2017

Fujun Shang

4

1 reference

3 August 2017

Jiuping Wang

5

1 reference

3 August 2017

Ye Zhang

6

1 reference

3 August 2017

Xiongtao Liu

7

1 reference

3 August 2017

Yuhui Yang

8

1 reference

3 August 2017

Li Liu

9

1 reference

3 August 2017

Qiangsun Zheng

10

1 reference

3 August 2017

publication date

13 November 2008

1 reference

Journal of Molecular and Cellular Cardiology

3 August 2017

published in

1 reference

3 August 2017

volume

46

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

169-176

1 reference

Atherosclerosis: immune and inflammatory aspects

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Autoimmune and inflammatory mechanisms in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

7 January 2021

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

7 January 2021

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

PD-1 and its ligands in T-cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Immune mechanisms in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Relevance of platelet-independent effects of aspirin to its salutary effect in atherosclerosis-related events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

TNF/TNFR family members in costimulation of T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

PD-1: an inhibitory immunoreceptor involved in peripheral tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

New regulatory co-receptors: inducible co-stimulator and PD-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Turning on the off switch: regulation of anti-viral T cell responses in the liver by the PD-1/PD-L1 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Current status and future directions of molecular markers in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Increased Th1 activity in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Cytokines in atherosclerosis: pathogenic and regulatory pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Innate and acquired immunity in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.028

10.1016/J.YJMCC.2008.10.028

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference